PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 1, 2018Skin Cancer0 citationsOpen Access

Trabectedin treatment for imatinib/pazopanib-resistant dermatofibrosarcoma protuberans : A case report

View Full Paper
YMYutaka MatsumuraYIYosuke IshitsukaSISae Inoue

Structured PICO

P
Population
1 adult (39-year-old male) with imatinib/pazopanib-resistant dermatofibrosarcoma protuberans with fibrosarcomatous changes (FS-DFSP) and lung/bone metastases
I
Intervention
Trabectedin

This case report describes the clinical course of a patient with imatinib/pazopanib-resistant dermatofibrosarcoma protuberans treated with trabectedin.

Abstract

39歳,男性。15年前に発症した20×10 cm大の腰部腫瘤。初診時左肺転移あり。病変の一部に線維肉腫様の構造を認め,繊維肉腫様変化を伴う隆起性皮膚線維肉腫(FS-DFSP)と診断し原発および肺転移を切除。1年後に右肺転移が出現し切除。2年後に骨転移も出現した。

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Matsumura et al. (2018) studied this question.

synapsesocial.com/papers/6a729c33febe604dd70ab00dhttps://doi.org/10.5227/skincancer.33.30
Ask AI
Helpful
Bookmark
Share
View Full Paper